|Bid||46.28 x 1200|
|Ask||46.30 x 1400|
|Day's range||46.28 - 46.46|
|52-week range||25.59 - 46.63|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||85.09|
|Earnings date||02 Aug 2021 - 06 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||47.27|
PPD has been named "Most Innovative CRO" by North Carolina’s Triangle Business Journal.
PPD held a grand opening event for its new multipurpose lab in Suzhou, China, to support pharma and biotech companies managing China research studies
PPD has been recognized for excellence in the CRO Leadership Awards, earning praise for its clinical research capabilities and customer compatibility.